NCT03207867 2024-10-09A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaNovartisPhase 2 Terminated315 enrolled 73 charts
NCT04432857 2024-06-27AN0025 and Pembrolizumab Combination in Advanced Solid TumorsAdlai Nortye Biopharma Co., Ltd.Phase 1 Active not recruiting63 enrolled